Xuzhou, China

Ping Dong

USPTO Granted Patents = 1 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ping Dong

Introduction

Ping Dong is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in addressing issues related to morphine-induced analgesic tolerance. His work is characterized by a focus on developing effective therapeutic solutions.

Latest Patents

Ping Dong holds a patent for a pharmaceutical composition and method for relieving or eliminating morphine-induced analgesic tolerance. This innovative composition includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically acceptable carrier. The short peptide consists of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously, or injecting the short peptide followed by morphine administration. This patent highlights his commitment to advancing medical treatments.

Career Highlights

Ping Dong is affiliated with Xuzhou Medical University, where he contributes to research and development in the pharmaceutical sciences. His work has garnered attention for its potential to improve pain management strategies and enhance patient outcomes.

Collaborations

Some of his notable coworkers include Qiongyao Tang and Zhe Zhang, who collaborate with him on various research projects. Their combined expertise fosters a productive environment for innovation and discovery.

Conclusion

Ping Dong's contributions to the field of pharmaceuticals, particularly through his patent addressing morphine-induced analgesic tolerance, underscore his role as a significant inventor. His work at Xuzhou Medical University and collaborations with fellow researchers further enhance the impact of his innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…